Canada markets close in 34 minutes

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
88.19+0.36 (+0.41%)
As of 03:26PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close87.83
Bid88.27 x 1100
Ask88.28 x 1200
Day's Range87.72 - 88.96
52 Week Range57.17 - 88.96
Avg. Volume8,449,153
Market Cap110.611B
Beta (5Y Monthly)0.44
PE Ratio (TTM)33.41
Earnings DateN/A
Forward Dividend & Yield2.92 (3.40%)
Ex-Dividend DateDec 14, 2022
1y Target EstN/A
  • Zacks

    Why Is Exelixis (EXEL) Up 0.4% Since Last Earnings Report?

    Exelixis (EXEL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Motley Fool

    The Top Healthcare Stocks to Buy With $100

    Although hard, it's not impossible, there are healthcare companies with solid earnings and dividend growth that can be had for less than a bill with Ben Franklin's picture on it. Gilead Sciences (NASDAQ: GILD) and Bristol Myers Squibb (NYSE: BMY) have posted triple-digit percentage gains over the past 10 years in revenue, earnings per share (EPS), and total return price. On top of that, shares of Gilead and Bristol can both be bought for less than $90 a share, at least for the time being.

  • Motley Fool

    2 Reasons This Stock Could Outperform in 2023

    Biotech giant Gilead Sciences (NASDAQ: GILD) is a member of this elite club, having seen its shares rise by 15% year to date. Let's consider two reasons why Gilead Sciences is worth serious consideration heading into the new year. Gilead Sciences' most important unit by some margin remains its HIV business.